Oslo, Norway

Marcel Sandberg

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Marcel Sandberg

Introduction

Marcel Sandberg, an accomplished inventor based in Oslo, Norway, has made significant contributions to the field of medicinal chemistry. With a total of seven patents to his name, he is recognized for his innovative work in developing compounds that address critical health issues, particularly in the areas of anti-inflammatory and antitumor therapies.

Latest Patents

Among his latest innovations are the anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds. These compounds are characterized by the formula (I), where specific selections of elements such as X, Y, and R lead to diverse chemical structures capable of therapeutic effects. Notably, these compounds can exist as salts, esters, solvates, N-oxides, or prodrugs, broadening the scope of their applicability in medicine.

Career Highlights

Marcel Sandberg has worked with notable companies such as Kappa Bioscience AS and Avexxin AS. His time in these organizations has enabled him to collaborate on cutting-edge research and product development, enhancing the pharmaceutical landscape through innovative solutions.

Collaborations

Throughout his career, Sandberg has worked alongside talented individuals such as Inger Reidun Aukrust and Berit Johansen. These collaborations have fostered an environment of creative problem-solving and helped bring his impactful inventions to fruition.

Conclusion

Marcel Sandberg's contributions to science and medicine through his patent portfolio and collaborative efforts embody the spirit of innovation. His work not only highlights the importance of research in developing effective therapies but also showcases the potential of inventive minds in driving progress within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…